Despite recommendations from the WHO and European medicines watchdog to continue using the vaccine, "Denmark's vaccination campaign will go ahead without the AstraZeneca vaccine," Danish Health Authority director Soren Brostrom told a press conference.
enmark on Tuesday announced it would stop using the AstraZeneca Covid-19 vaccine altogether, becoming the first European country to do so over suspected rare but serious side effects.
Despite recommendations from the WHO and European medicines watchdog to continue using the vaccine, "Denmark's vaccination campaign will go ahead without the AstraZeneca vaccine," Danish Health Authority director Soren Brostrom told a press conference.
Bloomberg reported that the country’s health authorities are due to brief reporters at 2 p.m. in Copenhagen. State broadcaster DR was among media outlets to report the decision, without saying how it obtained the information.
Denmark was one of the first countries to suspend the vaccine on March 11 after reports of blood clots. At the time, the Danish Health Authority called the decision a precautionary move and reiterated its view that Astra’s vaccine was “effective and safe.”
Both European and British drug regulators have said they found a link between Astra’s vaccine and blood clots, but said benefits still outweigh the risks. Most Western European countries have limited their use of the company’s vaccine to the elderly, while in Eastern Europe, Astra has largely been reinstated with no limitations.
Denmark’s Scandinavian neighbor, Norway, which has also kept Astra on hold since last month, is due to announce its decision on Thursday.
Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.
Thank you for sharing your thoughts. We appreciate your feedback.
Quickly share this news with your network—keep everyone informed with just a single click!
Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
Get the best experience—faster access, exclusive features, and a seamless way to stay updated.